{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-001552","form_type":"8-K","ticker":"LFMD","cik":"0000948320","company_name":"LifeMD, Inc.","filed_at":"2022-01-19T23:59:59+00:00","discovered_at":"2026-05-14T18:04:10.502414+00:00","generated_at":"2026-06-27T17:24:26.470417+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"LifeMD reports FY2021 preliminary revenue of $92.9M, +149% YoY; FY2022 guidance $142-148M","bullets":["Preliminary Q4 2021 revenue $27.4M; FY2021 revenue $92.9M (149% YoY growth).","FY2022 revenue guidance $142-148M; Adj. EBITDA loss guidance ($14M)-($20M).","Q1 2022 revenue guidance $30-32M; Adj. EBITDA loss ($6.5M)-($7.5M).","Reaffirms Adj. EBITDA profitability target by Q4 2022.","Company highlights acquisition of Cleared and launch of LifeMD Virtual Primary Care Platform."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-001552","json":"https://secwatch.observer/filing/0001493152-22-001552.json","markdown":"https://secwatch.observer/filing/0001493152-22-001552.md","text":"https://secwatch.observer/filing/0001493152-22-001552.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/948320/000149315222001552/0001493152-22-001552-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/948320/000149315222001552/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T17:24:26.470417+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}